Article Text

PDF
Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al
  1. Maya H Buch1,2
  1. 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
  2. 2NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  1. Correspondence to Professor Maya H Buch, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK; m.buch{at}leeds.ac.uk

Statistics from Altmetric.com

I would like to thank Roodenrijs et al1 for their thoughtful comments on my viewpoint ‘Defining refractory rheumatoid arthritis’2 and appreciate their acknowledgement of this important subgroup of patients with unmet clinical needs.

The authors highlight their description and recent review of ‘difficult to treat RA’3 that in contrast to my viewpoint includes refractory rheumatoid arthritis (RA) in the presence of persistent inflammation and in its absence. I acknowledge this approach is more inclusive in encompassing the breadth of reasons that contribute to challenging RA treatment decision making in real-world practice and …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles